View in EDS HTML Full Text PDF Full Text

Comprehensive molecular profiling of urologic tumors presented in a molecular tumor board: insights from a real-world precision oncology cohort.

Saved in:
Bibliographic Details
Title: Comprehensive molecular profiling of urologic tumors presented in a molecular tumor board: insights from a real-world precision oncology cohort.
Authors: Glienke M; Department of Urology, Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany.; Comprehensive Cancer Center Freiburg, Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany., Himmelsbach R; Department of Urology, Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany.; Comprehensive Cancer Center Freiburg, Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany., Zirngibl M; Department of Urology, Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany.; Comprehensive Cancer Center Freiburg, Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany., Metzger P; Comprehensive Cancer Center Freiburg, Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany.; Institute of Medical Bioinformatics and Systems Medicine, Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany.; Molecular Tumorboard Network (MTB) Freiburg, Freiburg, Germany.; German Cancer Consortium (DKTK), Partner Site Freiburg of the German Cancer Research Center (DKFZ), Heidelberg, Germany., Kühn J; Comprehensive Cancer Center Freiburg, Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany.; Molecular Tumorboard Network (MTB) Freiburg, Freiburg, Germany.; German Cancer Consortium (DKTK), Partner Site Freiburg of the German Cancer Research Center (DKFZ), Heidelberg, Germany.; Department of Medicine I, Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany., Miething C; Comprehensive Cancer Center Freiburg, Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany.; Molecular Tumorboard Network (MTB) Freiburg, Freiburg, Germany.; German Cancer Consortium (DKTK), Partner Site Freiburg of the German Cancer Research Center (DKFZ), Heidelberg, Germany.; Department of Medicine I, Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany., Sigle A; Department of Urology, Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany.; Comprehensive Cancer Center Freiburg, Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany.; Molecular Tumorboard Network (MTB) Freiburg, Freiburg, Germany.; German Cancer Consortium (DKTK), Partner Site Freiburg of the German Cancer Research Center (DKFZ), Heidelberg, Germany., Gratzke C; Department of Urology, Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany.; Comprehensive Cancer Center Freiburg, Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany., Nientiedt C; Department of Urology, Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany.; Comprehensive Cancer Center Freiburg, Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany.; Department of Medicine I, Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany., Rassner M; Comprehensive Cancer Center Freiburg, Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany.; Molecular Tumorboard Network (MTB) Freiburg, Freiburg, Germany.; German Cancer Consortium (DKTK), Partner Site Freiburg of the German Cancer Research Center (DKFZ), Heidelberg, Germany.; Department of Medicine I, Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany., Becker H; Comprehensive Cancer Center Freiburg, Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany.; Molecular Tumorboard Network (MTB) Freiburg, Freiburg, Germany.; German Cancer Consortium (DKTK), Partner Site Freiburg of the German Cancer Research Center (DKFZ), Heidelberg, Germany.; Department of Medicine I, Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany., Duyster J; Comprehensive Cancer Center Freiburg, Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany.; Molecular Tumorboard Network (MTB) Freiburg, Freiburg, Germany.; German Cancer Consortium (DKTK), Partner Site Freiburg of the German Cancer Research Center (DKFZ), Heidelberg, Germany.; Department of Medicine I, Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany., Lassmann S; Comprehensive Cancer Center Freiburg, Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany.; Molecular Tumorboard Network (MTB) Freiburg, Freiburg, Germany.; German Cancer Consortium (DKTK), Partner Site Freiburg of the German Cancer Research Center (DKFZ), Heidelberg, Germany.; Institute for Surgical Pathology, Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany., Werner M; Comprehensive Cancer Center Freiburg, Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany.; Molecular Tumorboard Network (MTB) Freiburg, Freiburg, Germany.; German Cancer Consortium (DKTK), Partner Site Freiburg of the German Cancer Research Center (DKFZ), Heidelberg, Germany.; Institute for Surgical Pathology, Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany., Börries M; Institute of Medical Bioinformatics and Systems Medicine, Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany.; Comprehensive Cancer Center Freiburg, Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany.; Molecular Tumorboard Network (MTB) Freiburg, Freiburg, Germany.; German Cancer Consortium (DKTK), Partner Site Freiburg of the German Cancer Research Center (DKFZ), Heidelberg, Germany., Grabbert M; Department of Urology, Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany.; Comprehensive Cancer Center Freiburg, Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany.; Molecular Tumorboard Network (MTB) Freiburg, Freiburg, Germany.; German Cancer Consortium (DKTK), Partner Site Freiburg of the German Cancer Research Center (DKFZ), Heidelberg, Germany.
Source: Frontiers in oncology [Front Oncol] 2025 Nov 27; Vol. 15, pp. 1688779. Date of Electronic Publication: 2025 Nov 27 (Print Publication: 2025).
Publication Type: Journal Article
Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101568867 Publication Model: eCollection Cited Medium: Print ISSN: 2234-943X (Print) Linking ISSN: 2234943X NLM ISO Abbreviation: Front Oncol Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:2234-943X
DOI:10.3389/fonc.2025.1688779